Clinical Trials Directory

Trials / Unknown

UnknownNCT05938829

Fetal Growth Restriction: Management Using Two Guidelines - Fetal Growth Antenatal Management Evaluation

Fetal Growth Restriction: Management Using Two Guidelines (FAME) - Fetal Growth Antenatal Management Evaluation

Status
Unknown
Phase
N/A
Study type
Interventional
Enrollment
1,100 (estimated)
Sponsor
The University of Texas Health Science Center, Houston · Academic / Other
Sex
All
Age
Healthy volunteers
Not accepted

Summary

The purpose of this study is to compare the composite neonatal adverse outcomes (CNAO) among pregnancies complicated by fetal growth restriction (FGR) managed using the Society of Maternal-Fetal Medicine (SMFM) versus International Society of Ultrasound in Obstetrics and Gynecology (ISUOG) antepartum ultrasound guidelines, to measure the rate of the individual components of CNAO, to record the rate of cesarean delivery during labor, to tabulate the rate of deviation from the management protocol assigned at the time of evaluation, to record neonatal intensive care unit (NICU) admission rates and to measure the rate of the composite maternal adverse outcome (CMAO).

Conditions

Interventions

TypeNameDescription
OTHERUltrasound following the SMFM guidelinesPatients will be followed with weekly ultrasound. During these scans, the patient will have a biophysical profile, a non-stress test (if the gestational age is over 32 weeks), and a Doppler interrogation of the fetal umbilical artery. This information will be captured in our ultrasound reporting software, Viewpoint.
OTHERUltrasound following the ISUOG guidelinesPatients will be followed with weekly ultrasound. During these scans, the patient will have a biophysical profile, a non-stress test (if the gestational age is over 32 weeks), and a Doppler interrogation of the fetal umbilical artery, middle cerebral artery, and ductus venosus. This information will be captured in our ultrasound reporting software, Viewpoint.

Timeline

Start date
2023-07-01
Primary completion
2025-07-15
Completion
2025-12-01
First posted
2023-07-11
Last updated
2023-07-11

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT05938829. Inclusion in this directory is not an endorsement.